Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Ile-Lys)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004389 AN007333 Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows Feces Pig Environmental stress North Carolina State University LC-MS
ST004389 AN007333 Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows Milk Pig Environmental stress North Carolina State University LC-MS
ST004290 AN007134 Metabolomics characterisation of Plasmodium falciparum response to plasmepsin V peptidomimetic inhibitors - 5 hour treatment Blood Plasmodium falciparum Malaria Monash University LC-MS
ST004194 AN006966 PfK13-associated artemisinin resistance slows drug activation and enhances antioxidant defence, which can be overcome with sulforaphane Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST004190 AN006961 Comparative Analysis of the Metabolic Profiles of Alix−/− and Ozz−/− Soleus Skeletal Muscle Muscle Mouse St Jude Children's Research Hospital LC-MS
ST004153 AN006894 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST003911 AN006421 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 Bacterial cells Eggerthella lenta Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003911 AN006421 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 Bacterial cells Fusobacterium nucleatum Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006418 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Bifidobacteria Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006418 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Clostridium Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006418 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Escherichia coli Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006418 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Streptococcus Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003880 AN006373 Untargeted metabolome analysis of control and disease intervertebral disc tissue Tissue Human Bone disease Ganga Orthopaedic Research and Education Foundation LC-MS
ST003799 AN006244 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 2. Cultured cells Dorea longicatena Colitis Broad Institute of MIT and Harvard LC-MS
ST003778 AN006205 Human to mouse microbiota transfer model demonstrates disease-modifying effects of the short-chain fatty acid biotherapy modified microbiota Feces Mouse Diabetes University of Queensland LC-MS
ST003565 AN005857 Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST003521 AN005783 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University LC-MS
ST003179 AN005221 Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST003144 AN005159 On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity Blood Plasmodium falciparum Malaria Monash University LC-MS
ST003053 AN005006 Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics Bacterial cells Staphylococcus aureus Bacterial infection Monash University LC-MS
ST003036 AN004977 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 Bacterial cells Pseudomonas aeruginosa Bacterial infection Monash Institute of Pharmaceutical Sciences LC-MS
ST003024 AN004958 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 Bacterial cells Pseudomonas aeruginosa Monash Institute of Pharmaceutical Sciences LC-MS
ST002977 AN004887 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002977 AN004889 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002926 AN004798 Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides fragilis Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides thetaiotaomicron Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides uniformis Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Blautia producta Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium clostridioforme Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hathewayi Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hylemonae Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium scindens Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium symbiosum Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecalis Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecium Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus hirae Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Escherichia fergusonii Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Flavonifractor plautii Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Parabacteroides distasonis Stanford University LC-MS
ST002792 AN004542 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002787 AN004534 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology LC-MS
ST002747 AN004454 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Human CZ Biohub LC-MS
ST002747 AN004454 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Rickettsia parkeri CZ Biohub LC-MS
ST002512 AN004136 Gnotobiotic mice: Metabolites in intestinal contents of germ-free mice colonized with strains of gut bacterium Eggerthella lenta Intestine Mouse University of California, San Francisco LC-MS
ST002512 AN004137 Gnotobiotic mice: Metabolites in intestinal contents of germ-free mice colonized with strains of gut bacterium Eggerthella lenta Intestine Mouse University of California, San Francisco LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002471 AN004033 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002412 AN003931 Metabolic effects of the protein kinase R Macrophages Mouse Hudson Institute of Medical Research LC-MS
ST002405 AN003919 Stool global metabolite levels in peanut allergy (Part 2) Feces Human Peanut allergy Icahn School of Medicine at Mount Sinai LC-MS
ST002309 AN003772 Targeting malaria parasites with novel derivatives of azithromycin Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002107 AN003446 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002106 AN003445 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST001955 AN003181 Metabonomics analysis reveals the physiological mechanism of promoting maize shoots growth under negative pressure to stabilize soil water content Leaf Maize Heilongjiang Bayi Agricultural University APCI-MS
ST001844 AN002987 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) Blood Human Fatty liver disease University of California, Davis GC-MS
ST001844 AN002987 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) Liver Human Fatty liver disease University of California, Davis GC-MS
ST001794 AN002912 Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples Jejunum Human University of California, Davis LC-MS
ST001788 AN002899 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University LC-MS
ST001549 AN002580 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University LC-MS
ST001547 AN002576 β-Adrenergic regulation of metabolism in macrophages Macrophages Human Monash University LC-MS
ST001324 AN002202 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Hepatopancreas Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences LC-MS
ST001315 AN002190 Retargeting azithromycin-like compounds as antimalarials with dual modality Blood Plasmodium falciparum Malaria Monash University LC-MS
ST001274 AN002115 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) Cultured cells Trypanosoma brucei Sleeping sickness Monash University LC-MS
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST000546 AN000832 Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium Cells Plasmodium falciparum Malaria Monash University LC-MS
  logo